Diagnosis and treatment of portal hypertension

Digestive and Liver Disease

Volumn 36, Issue 12, 2004, Pages 787-798

  de Franchis, R ^a   Dell'Era, A ^a   Iannuzzi, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Beta blockers; Confidence intervals; Endoscopic sclerotherapy; Meta analysis; Number needed to treat; Odds ratio; TIPS; Variceal bleeding; Vasoactive drugs

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE; NADOLOL; OCTREOTIDE; PROPRANOLOL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RUBBER; SOMATOSTATIN; SUCRALFATE; TERLIPRESSIN; TIMOLOL; VAPREOTIDE; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG FATALITY; DRUG HYPERSENSITIVITY; ENDOSCOPIC THERAPY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEIN; HUMAN; INFECTION CONTROL; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRESSURE GRADIENT; REVIEW; SCLEROTHERAPY; TREATMENT FAILURE; VEIN LIGATION; LIGATION; LIVER CIRRHOSIS; LIVER VEIN; PATHOPHYSIOLOGY; RETREATMENT;

ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEPATIC VEINS; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; PATIENT SELECTION; RETREATMENT; SCLEROTHERAPY; TREATMENT FAILURE;

EID: 14644390922     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.08.001     Document Type: Short Survey

References (115)

1. E. Christensen L. Fauerholdt P. Schlichting E. Juhl H. Poulsen N. Tygstrup Aspects of natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone Gastroenterology 81 1981 944-952
2. G. D'Amico A. Luca Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding In: J. Bosch editor. Bailliere's clinical gastroenterology - portal hypertension vol. 11 1997 Bailliere Tindall London 243-256
3. North-Italian Endoscopic Club for the Study and Treatment of Esophageal Varices Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices N. Engl. J. Med. 319 1988 983-989
4. G. D'Amico L. Pagliaro J. Bosch Pharmacologic treatment of portal hypertension: An evidence-based approach Semin. Liver Dis. 19 1999 475-505
5. G. D'Amico R. de Franchis Cooperative Study Group Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators Hepatology 38 2003 599-612
6. N. Chalasani C. Kahi F. Francois A. Pinto A. Marathe E.J. Bini et al. Improved patient survival after acute variceal bleeding: A multicenter cohort study Am. J. Gastroenterol. 98 2003 653-659
7. R. de Franchis M. Primignani Natural history of portal hypertension in patients with cirrhosis In: A. Sanyal editor. Portal hypertension. Clinics in liver disease vol. 5 2001 Saunders Philadelphia 645-663
8. G. D'Amico A. Luca Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding Baillieres Clin. Gastroenterol. 11 1997 243-256
9. D. Graham J.L. Smith The course of patients after variceal hemorrhage Gastroenterology 80 1981 800-806
10. R. de Franchis J.P. Pascal E. Ancona A.K. Burroughs M. Henderson W. Fleig et al. Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop, Baveno, Lake Maggiore, Italy, April 5, 1990 J. Hepatol. 15 1992 256-261
11. R.J. Groszmann S. Wongcharatrawee The hepatic vein pressure gradient: anything worth doing should be done right Hepatology 39 2004 280-282
12. J. Bosch J.C. Garcia-Pagan Pathophysiology of portal hypertension and its complications In: J. Bircher J.P. Benhamou N. McIntire M. Rizzetto J. Rodes editors. Oxford textbook of clinical hepatology 1999 Oxford University Press Oxford 653-659
13. G. Garcia-Tsao R. Groszmann R. Fisher H.O. Conn C.E. Atterbury M. Glickman Portal pressure, presence of gastroesophageal varices and variceal bleeding Hepatology 5 1985 419
14. F. Feu J.C. Garcia-Pagan J. Bosch A. Luca J. Teres A. Escorsell et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis Lancet 346 1995 1056-1059
15. C. Merkel M. Bolognesi S. Bellon R. Zuin F. Noventa G. Finucci et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices Gastroenterology 102 1992 973-979
16. C. Sabbà C. Merkel M. Zoli G. Ferraioli S. Gaiani D. Sacerdoti et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: Effect of a cooperative training program Hepatology 21 1995 428-433
17. G. D'Amico G. Garcia-Tsao P. Calès A. Escorsell F. Nevens R. Cestari et al. Diagnosis of portal hypertension: How and when In: R. de Franchis editor. Portal hypertension III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies 2000 Blackwell Science Oxford, UK 36-64
18. Pascal JP, Calès P, Desmorat H. Natural history of esophageal varices. In: Bosch J, Rodès J, editors. Recent advances in the pathophysiology and treatment of portal hypertension. Serono Symposia review no. 22; Rome, Italy; 1989. p. 127-42
19. L. Pagliaro G. D'Amico L. Pasta F. Politi G. Vizzini M. Traina et al. Portal hypertension in cirrhosis: Natural history In: J. Bosch RJ. Groszmann editors. Portal hypertension, pathophysiology and treatment 1994 Blackwell Scientific Publications Oxford 72-92
20. G. Garcia-Tsao A. Escorsell M. Zakko D. Patch D. Matloff N. Grace et al. Predicting the presence of significant portal hypertension and esophageal varices in compensated cirrhotic patients Hepatology 26 1997 360A [abstract]
21. C. Pilette F. Oberti C. Aube M.C. Rousselet P. Bedoussa Y. Gallois et al. N-invasive diagnosis of esophageal varices in chronic liver disease J. Hepatol. 31 1999 867-873
22. N. Chalasani T.F. Imperiale A. Ismail G. Sood M. Carey C.M. Wilcox et al. Predictors of large esophageal varices in patients with cirrhosis Am. J. Gastroenterol. 94 1999 3285-3291
23. F. Schepis C. Cammà D. Niceforo A. Magnano S. Pallio M. Cinquegrani et al. Which patients should undergo endoscopic screening for esophageal varices detection? Hepatology 33 2001 333-338
24. A. Zaman T. Becker J. Lapidus K. Benner Risk factors for the presence of varices in cirrhotic patients without history of variceal hemorrhage Arch. Int. Med. 161 2001 2564-2570
25. R. Madhotra H.E. Mulcahy I. Willner A. Reuben Prediction of esophageal varices in patients with cirrhosis J. Clin. Gastroenterol. 34 2002 81-85
26. O. Riggio S. Angeloni G. Nicolini M. Merli C. Merkel Endoscopic screening for esophageal varices in cirrhotic patients Hepatology 35 2002 501-502 [letter]
27. R. de Franchis Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension J. Hepatol. 33 2000 846-852
28. M. Primignani R. Albè P. Preatoni P. Carnevale M.B. Bianchi E. Parravicini et al. 'De novo' development of esophageal varices in patients with a recent histologic diagnosis of liver cirrhosis Gastroenterology 114 1998 A1324 [abstract]
29. M. Merli G. Nicolini S. Angeloni V. Rinaldi A. De Santis C. Merkel et al. Incidence and natural history of small oesophageal varices in cirrhotic patients J. Hepatol. 38 2003 266-272
30. R. de Franchis A. Dell'Era L. Fazzini S. Zatelli V. Savojardo M. Primignani Evaluation and follow-up of patients with portal hypertension and esophageal varices: How and when Dig. Liver Dis. 33 2001 643-646
31. G.P. Rigo A. Merighi N.J. Chahin M. Mastronardi P.L. Codeluppi A. Ferrari et al. A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices Gastrointest. Endosc. 38 1992 425-429
32. E. Colombo M.A. Casiraghi G. Minoli A. Prada V. Terruzzi A. Bortoli et al. First bleeding episode from oesophageal varices: A prospective study of endoscopic predictive factors Ital. J. Gastroenterol. 27 1995 345-348
33. M. Zoli C. Merkel D. Magalotti G. Marchesini A. Gatta E. Pisi Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis Hepatology 24 1996 247-252
34. J.C. Garcia-Pagan M. Navasa J. Bosch C. Bru P. Pizcueta J. Rodés Enhancement of portal pressure reduction by the association of isosorbide-5 mononitrate to propranolol administration in patients with cirrhosis Hepatology 11 1990 330-338
35. P. Calés F. Oberti J.L. Payen S. Naveau D. Guyader P. Blanc et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: A randomized trial Eur. J. Gastroenterol. Hepatol. 11 1999 741-745
36. R. Groszmann G. Garcia-Tsao R. Makuch J. Bosch A. Escorsell J.C. Garcia-Pagan et al. Multicenter randomized trial of non-selective beta-blockers in the prevention of complications of portal hypertension: final results and identification of a predictive factor Hepatology 38 2003 206A
37. C. Merkel R. Marin P. Angeli P. Zanella M. Felder E. Bernardinello et al. Beta-blockers in the prevention of the aggravation of esophageal varices in patients with cirrhosis and small varices: A placebo-controlled clinical trial Hepatology 38 2003 217A
38. H.O. Conn W.W. Lindenmuth C.J. May G.R. Ramsby Prophylactic portacaval anastomosis: A tale of two studies Medicine 51 1972 27-40
39. G. D'Amico L. Pagliaro J. Bosch The treatment of portal hypertension: A meta-analytic review Hepatology 22 1995 332-354
40. R. de Franchis M. Primignani Endoscopic treatments for portal hypertension Semin. Liver Dis. 19 1999 439-455
41. R. de Franchis Developing consensus in portal hypertension J. Hepatol. 25 1996 390-394
42. R. Groszmann J. Bosch N.D. Grace H.O. Conn G. Garcia-Tsao M. Navasa et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage Gastroenterology 99 1990 1401-1407
43. B. Bernard D. Lebrec P. Mathurin P. Opolon T. Poynard Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis J. Hepatol. 26 1997 312-324
44. B. Bernard D. Lebrec P. Mathurin P. Opolon T. Poynard Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis Hepatology 25 1997 63-70
45. M. Bolognesi G. Balducci G. Garcia-Tsao A. Gatta P. Ginès M. Merli et al. Complications of the medical treatment of portal hypertension In: R. de Franchis editor. Portal hypertension III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies 2001 Blackwell Science Oxford 180-201
46. M. Angelico L. Carli C. Piat S. Gentile V. Rinaldi E. Bologna et al. Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis Gastroenterology 104 1993 1460-1465
47. M. Angelico L. Carli C. Piat S. Gentile L. Capocaccia Isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis Gastroenterology 113 1997 1632-1639
48. G. Borroni F. Salerno M. Cazzaniga F. Bissoli E. Lorenzano A. Maggi et al. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites J. Hepatol. 37 2002 315-321
49. J.C. Garcia Pagán C. Villanueva C. Vila A. Albillos J. Genescà L. Ruiz-del-Arbol et al. Isosorbide-5-mononitrate in the prevention of the first variceal bleed in patients who cannot receive beta-blockers Gastroenterology 121 2001 908-914
50. C. Merkel R. Marin E. Enzo C. Donada G. Cavallarin P. Torboli et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis Lancet 348 1996 1677-1681
51. G. Pietrosi G. D'Amico L. Pasta R. Patti G. Vizzini M. Traina et al. Isosorbide mononitrate (IMN) with nadolol compared to nadolol alone for prevention of first bleeding in cirrhosis: A double blind placebo-controlled randomised trial J. Hepatol. 30 1999 66 [abstract]
52. JC. Garcia-Pagán R. Morillas R. Bañares A. Albillos C. Villanueva C. Vila et al. Propranolol + placebo vs. propranolol + isosorbide-5-mononitrate in the prevention of the first variceal bleed. A double blind RCT Hepatology 37 2003 1260-1266
53. S.K. Sarin R.K.C. Guptan A.K. Jain K.R. Sundaram A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding Eur. J. Gastroenterol. Hepatol. 8 1996 337-342
54. C.S. Lay Y.T. Tsai C.Y. Teg W.S. Shyu W.S. Guo K.L. Wu et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices Hepatology 25 1997 1346-1350
55. C.Y. Chen C.Y. Chen T.T. Chang Prophylactic endoscopic variceal ligation for esophageal varices Gastroenterology 112 1997 A1240 [abstract]
56. K. Gameel I. Waked S. Saleh M. Sallam S. Abdel-Fattah Prophylactic endoscopic variceal band ligation (EVL) versus sclerotherapy (EVS) for the prevention of variceal bleeding in high-risk varices: A prospective randomized controlled trial Hepatology 26 1997 361A [abstract]
57. G.H. Lo K.H. Lai J.S. Cheng C.K. Lin P.I. Hau H.T. Chiang Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: A prospective randomized trial J. Hepatol. 31 1999 451-456
58. T.F. Imperiale N. Chalasani A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding Hepatology 33 2001 802-807
59. C.Y. Chen M.Z. Sheu S.Y. Su Prophylactic endoscopic variceal ligation (EVL) with multiple band ligator for esophageal varices Gastroenterology 114 1998 A1224 [abstract]
60. S.K. Sarin G.S. Lamba M. Kumar A. Misra N.S. Murthy Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding N. Engl. J. Med. 340 1999 988-993
61. I.H. Song J.W. Shin I.H. Kim J. Choi C.Y. Lin J.W. Kim et al. A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high-risk esophageal varices J. Hepatol. 32 2000 41 [abstract]
62. R. Jutabha D.M. Jensen P. Martin T.J. Savides L. Chapman M.E. Jensen et al. A randomized, prospective study of prophylactic rubber band ligation compared to propranolol for prevention of first variceal hemorrhage in cirrhotics with large esophageal varices Gastrointest. Endosc. 53 2001 AB70 [abstract]
63. H.F. Lui A.J. Stanley E.H. Forrest R. Jalan W.S. Hislop P.R. Mills et al. Primary prophylaxis of variceal hemorrhage: A randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate Gastroenterology 123 2002 735-744
64. C. Gheorghe L. Gheorghe R. Vadan D. Hrehoret I. Popescu Prophylactic banding ligation of high-risk esophageal varices in patients on the waiting list for liver transplantation: An interim analysis J. Hepatol. 36 2002 38 [abstract]
65. M. Schepke C. Goebel D. Nuernberg J. Willert L. Koch T. Sauerbruch Endoscopic banding ligation versus propranolol for the primary prevention of variceal bleeding in cirrhosis: A randomized controlled multicenter trial Hepatology 38 2003 218A
66. G.H. Lo W.C. Chen M.H. Chen C.P. Lin C.C. Lo P.I. Hsu et al. Endoscopic ligation vs. nadoilol in the prevention of first variceal bleeding in patients with cirrhosis Gastrointest. Endosc. 59 2004 333-338
67. C. Bureau J.M. Péron L. Alric J. Morales J. Sanchez K. Barange et al. 'A la carte' treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding Hepatology 36 2002 1361-1366
68. L. Pagliaro G. D'Amico L. Pasta E. Aragona F. Politi G. Malizia et al. Efficacy and efficiency of treatments in portal hypertension In: R. de Franchis editor. Portal hypertension II. Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies 1996 Blackwell Oxford 159-179
69. P.A. McCormick L. Greenslade L.A. Matheson M. Matsaganis N. Bosanquet A.K. Burroughs Vasoconstrictors in the management of bleeding from oesophageal varices. A clinicoeconomical appraisal in the UK Scand. J. Gastroenterol. 30 1995 377-383
70. D. Nidegger S. Ragot P. Berthélemy C. Masliah C. Pilette T. Martin et al. Cirrhosis and bleeding: The need for very early management J. Hepatol. 39 2003 509-514
71. D. Kravetz J. Bosch M. Arderiu P. Pizcueta J. Rodés Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal-systemic shunting Hepatology 9 1989 808-814
72. B. Castañeda J. Morales R. Lionetti E. Moitinho V. Andreu S. Perez-del-Pulgar et al. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats Hepatology 33 2001 821-825
73. Z. Ben-Ari F. Cardin P.A. McCormick G. Wannamethee A.K. Burroughs A predictive model for failure to control bleeding during acute variceal hemorrhage J. Hepatol. 31 1999 443-450
74. A. Escorsell J.M. Bordas L. Ruiz del Arbol J. Jaramillo R. Planas R. Bañares et al. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis J. Hepatol. 29 1998 779-788
75. A. Escorsell L. Ruiz del Arbol R. Planas A. Albillos R. Bañares P. Calés et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: The TEST study Hepatology 32 2000 471-476
76. E. Moitinho R. Planas R. Bañares A. Albillos L. Ruiz del Arbol C. Galvez et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding J. Hepatol. 35 2001 712-718
77. S. Levacher P.H. Letoumelin D. Paternon M. Blaise C. Lepandry J.L. Pourriat Early administration of terlipressin plus glyceryltrinitrate for active upper gastrointestinal hemorrhage in cirrhotic patients Lancet 346 1995 865-868
78. I. Besson P. Ingrand B. Person D. Boutroux D. Heresbach P. Bernard et al. Sclerotherapy with or without octreotide for acute variceal bleeding N. Engl. J. Med. 333 1995 555-560
79. J.J. Sung S.C.S. Chung M.Y. Yung C.W. Lai J.Y.W. Lau Y.T. Lee et al. Prospective randomised study of effect of octreotide on rebleeding from esophageal varices after endoscopic ligation Lancet 346 1995 1666-1669
80. S. Signorelli F. Negrini B. Paris M. Bonelli M. Girola Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal hemorrhage: Our experience Gastroenterology 110 1996 A1326 [abstract]
81. S. Brunati R. Ceriani R. Curioni L. Brunelli G. Repaci L. Morini Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal hemorrhage Hepatology 24 1996 207A [abstract]
82. A.K. Burroughs Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trial failures Hepatology 24 1996 352A [abstract]
83. S. Signorelli B. Paris F. Negrin M. Bonelli M. Auriemma Esophageal varices bleeding: Comparison between treatment with sclerotherapy alone vs. sclerotherapy plus octreotide Hepatology 26 1997 137 [abstract]
84. A. Avgerinos F. Nevens S. Raptis J. Fevery Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial Lancet 350 1997 1495-1499
85. B.F. Zuberi Q. Baloch Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis Am. J. Gastroenterol. 95 2000 768-771
86. P. Calés C. Masliah B. Bernard P.P. Garnier C. Silvain N. Szostak-Talbodec et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis N. Engl. J. Med. 344 2001 23-28
87. R. Bañares A. Albillos D. Rincon S. Alonso M. Gonzalez L. Ruiz del Arbol et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis Hepatology 35 2002 609-615
88. C. Villanueva J. Ortiz M. Sàbat A. Gallego X. Torras G. Soriano et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: A prospective randomized trial Hepatology 30 1999 384-389
89. M.T. Novella C. Villanueva J. Ortiz J. Pamplona S. Sainz G. Soriano et al. Octreotide vs. sclerotherapy and octreotide for acute variceal bleeding: A pilot study Hepatology 24 1996 207A [abstract]
90. E. Ejlersen T. Melsen J. Ingerslev R.B. Andreasen H. Vilstrup Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices Scand. J. Gastroenterol. 36 2001 1081-1085
91. D. Thabut R. de Franchis F. Bendtsen G. D'Amico A. Albillos J.G. Abraldes et al. Efficacy of activated recombinant factor VIII (RFVIIa; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: A randomised placebo-controlled double-blind multicenter trial J. Hepatol. 38 Suppl 2 2003 13 [abstract]
92. B. Bernard J.F. Cadranel D. Valla S. Escolano V. Jarlier P. Opolon Prognostic significance of bacterial infection in bleeding cirrhotic patients Gastroenterology 108 1995 1828-1834
93. M. Deschenes J.P. Villeneuve Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis Am. J. Gastroenterol. 94 1999 2001-2003
94. M. Borzio F. Salerno L. Piantoni M. Cazzaniga P. Angeli F. Bissoli et al. Bacterial infection in patients with advanced cirrhosis: A multicenter prospective study Dig. Liver Dis. 33 2001 41-48
95. S. Vivas M. Rodriguez M.A. Palacio A. Linares J.L. Alonso L. Rodrigo Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding Dig. Dis. Sci. 46 2001 2752-2757
96. D. Almeida A.A. Lopes R. Santos-Jesus I. Paes H. Bittencourt R. Parana Comparative study of bacterial infection prevalence between cirrhotic patients with and without upper gastrointestinal bleeding Braz. J. Infect. Dis. 5 2001 136-142
97. J. Goulis D. Patch A.K. Burroughs Bacterial infection in the pathogenesis of variceal bleeding Lancet 353 1999 139-142
98. P. Montalto J. Vlachogiannakos D.J. Cox S. Pastacaldi D. Patch A.K. Burroughs Bacterial infection in cirrhosis impairs coagulation by a heparin effect: A prospective study J. Hepatol. 37 2002 463-470
99. B. Bernard J.D. Grangé E.N. Khac X. Amiot P. Opolon T. Poynard Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis Hepatology 29 1999 1655-1661
100. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002:CD002907
101. M. Vangeli D. Patch A.K. Burroughs Salvage TIPS for uncontrolled variceal bleeding J. Hepatol. 37 2002 703-704
102. R. Jalan T.G. John D.N. Redhead O.J. Garden K.J. Simpson N.D. Finlayson et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage Am. J. Gastroenterol. 90 1995 1932-1937
103. L. Pagliaro A.K. Burroughs T.I.A. Soerensen D. Lebrec A. Morabito G. D'Amico et al. Therapeutic controversies and randomised controlled trials (RCTs): Prevention of bleeding and rebleeding in cirrhosis Gastroenterol. Int. 2 1989 71-84
104. G.P. Spina J.M. Henderson L.F. Rikkers J. Teres A.K. Burroughs H.O. Conn et al. Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding J. Hepatol. 16 1992 338-345
105. A.S. Rosemurgy F.M. Serafini B.R. Zweibel T.J. Black B.T. Kudryk H.J. Nord et al. Transjugular intrahepatic portosystemic shunt vs. small diameter prosthetic H-graft portacaval shunt: Extended follow-up of an expanded randomized prospective trial J. Gastrointest. Surg. 4 2000 589-597
106. A.S. Rosemurgy E.E. Zervos M. Bloomston A.J. Durkin W.C. Clark S. Goff Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve Ann. Surg. 237 2003 825-827
107. C. Villanueva J. Balanzò M.T. Novella G. Soriano G. Sainz X. Torras et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding N. Engl. J. Med. 334 1996 1624-1629
108. C. Villanueva J. Miñana J. Ortiz A. Gallego G. Soriano X. Torras et al. Endoscopic ligation compared with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding N. Engl. J. Med. 345 2002 647-655
109. G.H. Lo W.C. Chen M.H. Chen P.I. Hsu C.K. Lin W.L. Tsai et al. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding Gastroenterology 123 2002 728-734
110. D. Patch C.A. Sabin J. Goulis G. Gerunda L. Greenslade C. Merkel et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis Gastroenterology 123 2002 1013-1019
111. G.H. Lo K.H. Lai J.S. Cheng M.H. Chen H.C. Huang P.L. Hsu et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective, randomized trial Hepatology 32 2000 461-465
112. G.V. Papatheodoridis J. Goulis G. Leandro D. Patch A.K. Burroughs Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis Hepatology 30 1999 612-622
113. A. Luca G. D'Amico R. La Galla M. Midiri A. Morabito L. Pagliaro TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials Radiology 212 1999 411-421
114. P. Meddi M. Merli R. Lionetti A. De Santis V. Valeriano A. Masini et al. Cost analysis for the prevention of variceal rebleeding: A comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in selected group of Italian cirrhotic patients Hepatology 29 1999 1074-1077
115. M.W. Russo S.L. Zacks R.S. Sandler R.S. Brown Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding Hepatology 31 2000 358-363